#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Interstitial lung disease

Recruiting

Registered drug

Study on the Effects of Morphine Sulfate for Relieving Breathlessness and Cough in Patients with Fibrotic Interstitial Lung Disease

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Morphine Sulfate

Contact Research Centre

Interstitial lung disease

Recruiting

Registered drugNo placebo

Study to evaluate oxygen therapy effects on physical activity in patients with fibrotic interstitial lung disease who experience low oxygen levels during exercise

Registered drugNo placebo

Spain

Participants:65+ years
Substances:Oxygen

Contact Research Centre

Interstitial lung disease

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Inhaled Treprostinil for Patients with Fibrotic Lung Disease

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Treprostinil

Contact Research Centre

Interstitial lung disease

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Interstitial lung disease

Recruiting

Registered drug

Study on the Effects of Wharton's Jelly Mesenchymal Stem Cells, Pirfenidone, and Nintedanib for Patients with Fibrotic Interstitial Lung Disease

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Nintedanib

Contact Research Centre

Interstitial lung disease

Not yet recruiting

Registered drugNo placebo

Immunomodulatory Treatment with Prednisone, Azithromycin and Hydroxychloroquine in Patients with Surfactant‑Related Gene Mutation Interstitial Lung Disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azithromycin

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

InvestigationalNo placebo

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:ADMILPARANT

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

Registered drugNo placebo

Carboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Interstitial lung disease+1

Not yet recruiting

Registered drug

Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Interstitial lung disease+1

Not recruiting

Investigational

Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol

Contact Research Centre

Interstitial lung disease

Not recruiting

Registered drugNo placebo

Study on the Effects of High-Flow Oxygen Therapy in Patients with Interstitial Lung Disease During Exercise

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Oxygen

Contact Research Centre

Interstitial lung disease

Not recruiting

InvestigationalNo placebo

Study on Pirfenidone Inhalation Solution for Patients with Progressive Fibrosing Interstitial Lung Diseases, Including Idiopathic Pulmonary Fibrosis

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Pirfenidone

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.